GeneDx Holdings (WGS) Deferred Taxes (2022 - 2026)
GeneDx Holdings has reported Deferred Taxes over the past 5 years, most recently at $897000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 100.67% to $897000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Mar 2026, up 623.12% year-over-year, with the annual reading at -$343000.0 for FY2024, 62.96% up from the prior year.
- Deferred Taxes was $897000.0 for Q1 2026 at GeneDx Holdings, up from $246000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $897000.0 in Q1 2026 and troughed at -$49.1 million in Q2 2022.
- The 5-year median for Deferred Taxes is -$99000.0 (2022), against an average of -$3.3 million.
- Year-over-year, Deferred Taxes plummeted 890.38% in 2023 and then surged 645.12% in 2025.
- A 5-year view of Deferred Taxes shows it stood at $52000.0 in 2022, then plummeted by 890.38% to -$411000.0 in 2023, then soared by 94.16% to -$24000.0 in 2024, then soared by 1125.0% to $246000.0 in 2025, then skyrocketed by 264.63% to $897000.0 in 2026.
- Per Business Quant, the three most recent readings for WGS's Deferred Taxes are $897000.0 (Q1 2026), $246000.0 (Q3 2025), and -$245000.0 (Q2 2025).